| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/06/2001 | US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents |
| 03/06/2001 | US6197584 Antisense modulation of CD40 expression |
| 03/06/2001 | US6197582 Development of human monoclonal antibodies and uses thereof |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197571 Protein polysaccharide 0041 |
| 03/06/2001 | US6197528 Composition of immunotoxins and retinoids and use thereof |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 03/06/2001 | US6197511 Amino acid sequence; diagosis and treatment of cancer and skin disorders; anticarcinogenic agents; recombinant production; hybridization probes |
| 03/06/2001 | US6197341 Formulations of balsalazide and its derivatives |
| 03/06/2001 | US6197311 Induction of cytotoxic T-lymphocyte responses |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA2223081C Heterocyclic ring-fused pyrimidine derivatives |
| 03/06/2001 | CA2183655C 4-polycyclic amino-substituted quinazoline derivatives |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014542A1 A transmembrane trap for isolating membrane bound proteins |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
| 03/01/2001 | WO2001014405A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | WO2001014402A1 Antisense modulation of focal adhesion kinase expression |
| 03/01/2001 | WO2001014401A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 03/01/2001 | WO2001014395A2 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 03/01/2001 | WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/01/2001 | WO2001014379A2 A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
| 03/01/2001 | WO2001014375A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014365A1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS |
| 03/01/2001 | WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 03/01/2001 | WO2001014354A1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 03/01/2001 | WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001014324A1 Selective inhibitors of the urokinase plasminogene activators |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001014316A1 Substituted chiral allosteric hemoglobin modifiers |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013940A1 Hm1.24 antigen expression potentiators |
| 03/01/2001 | WO2001013929A1 Antineoplastic extract from achillea millefolium |
| 03/01/2001 | WO2001013901A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000073415A3 A method for the transfer of antigens to dendritic cells |
| 03/01/2001 | WO2000071752A3 Assay for the detection of paclitaxel resistant cells in human tumors |
| 03/01/2001 | WO2000071708A3 Use of ef-ts for treating smooth muscle cell hyperplasia |
| 03/01/2001 | WO2000068223A8 Ureas and their use as cell adhesion modulators |
| 03/01/2001 | WO2000061141A3 Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| 03/01/2001 | WO2000052031A3 Kit for radiolabeling proteins with yttrium-90 |
| 03/01/2001 | WO2000030660A3 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 03/01/2001 | WO1999043314A9 Farnesyl-protein transferase inhibitors |
| 03/01/2001 | DE19940748A1 Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide Medicament comprising xenogenic oligo- or / and polyribonucleotides |
| 03/01/2001 | DE19940389A1 Selektive Inhibitoren des Urokinase-Plasminogen Aktivators Selective inhibitors of urokinase plasminogen activator |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | DE19939981A1 Neue Inhibitoren des Integrins alphavß3 New inhibitors of integrin alphavß3 |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | DE19933075A1 Nicht-menschliches Säugetier mit gewebespezifisch verändertem Glukokortikoidrezeptor A non-human mammal with a tissue-specific glucocorticoid receptor modified |
| 03/01/2001 | DE10036854A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2384511A1 Substituted chiral allosteric hemoglobin modifiers |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
| 03/01/2001 | CA2382850A1 Novel inhibitors of the integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382587A1 Hm1.24 antigen expression potentiators |
| 03/01/2001 | CA2382561A1 Inhibitors of integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382467A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 03/01/2001 | CA2382315A1 Antineoplastic extract from achillea millefolium |
| 03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2382101A1 A transmembrane trap for isolating membrane bound proteins |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 02/28/2001 | EP1078634A1 Medicament for inhibiting NF-kB |
| 02/28/2001 | EP1078267A1 Assays, methods and means for modulating e2f activity |
| 02/28/2001 | EP1078091A2 Gene therapy vectors and their use in antitumour therapy |
| 02/28/2001 | EP1078070A2 Human nucleic acid methylases |
| 02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078058A2 Prostate growth-associated membrane proteins |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078043A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 02/28/2001 | EP1078003A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) |
| 02/28/2001 | EP1078002A1 Peptide antiangiogenic drugs |
| 02/28/2001 | EP1078001A2 Il-6 antagonist peptides |
| 02/28/2001 | EP1078000A2 Peptides |
| 02/28/2001 | EP1077997A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |